Navigation Links
FlexDrop IV Precision Reagent Dispenser

ProductsFlexDrop IV Precision Reagent Dispenser
Company PerkinElmer Life And Analytical Sciences, Inc.
Item FlexDrop IV Precision Reagent Dispenser
Features Inquire
Description FlexDrop provides rapid reagent dispensing of reagents, buffers and solvents for plate preparation and assay development. Enables dispensing through eight nozzle manifolds for fast throughput. Four models are available, with systems for dispensing one, two or four reagents into 96-, 384-, 1536-and deepwell microplates at volumes from 200 nL to 2.0 mL with <5% C.V. across all volume ranges.
Info PerkinElmer Life And Analytical Sciences, Inc.
Customer Service: (800) 762-4000
Web site: http://www.perkinelmer.com

Related medicine products :

1. FlexDrop III Precision Reagent Dispenser
2. Precisionist Phacoemulsification System
3. Precision Programmable Autoclaves
4. Precision Economy Incubators 3EM
5. Precision Economy Incubators 5EM
6. Precision Economy Incubators 2EG
7. Precision Economy Incubators 3EG
8. Precision Economy Incubators 5EG
9. Pocket II Precision Pachymeter
10. Precision Xtra Advanced Diabetes Tester
11. Precision Net
... Sorvall DiscoveryTMM150 SE Micro-ultra centrifuge continues to ... sample processing, now with 1,048,000 x g ... rotor. DiscoveryTMM150SE processes sample sizes from ... small floor footprint, brushless direct drive, very ...
... and environmental safety are the ... K Ultracentrifuge from Beckman Coulter. ... centrifugation technology, the LE-80 K ... provide advanced capability for your ...
... Optima L-XP ultracentrifuge is designed to ... discovery process if research involves proteomics, ... sophisticated on-board computer, enhanced firmware, powerful ... touch screen, Optima L-XP delivers superior ...
... chemistry system brings versatility in a ... laboratory. A model of innovation and ... system features state-of-the-art Dimension testing technology, ... in a flexible. affordable, easy-to-use system ...
Medicine Products:
(Date:4/18/2014)... April 18, 2014) Benaroya Research Institute at Virginia ... blocking a particular molecule in metastatic breast cancer reduces ... of lung metastases. BRI scientists have found in models ... tumors by 60 - 80 percent and can keep ... The $1.8 million five-year grant comes from the National ...
(Date:4/17/2014)... presence of chronic inflammation in benign prostate tissue ... and this association was found even in those ... a study published in Cancer Epidemiology, Biomarkers ... Association for Cancer Research. , An analysis of ... the placebo arm of the Prostate Cancer Prevention ...
(Date:4/17/2014)... today in PLOS Pathogens , children who live ... can mount an immune response to infection with malaria ... of high fever and illness and partially control the ... may help researchers develop future interventions that prevent or ... Each year, approximately 200 million cases of malaria occur ...
(Date:4/17/2014)... McCullers, MD, was recently invited to submit a ... Reviews Microbiology , one of the world,s foremost ... disease specialist, and chair of the Department of ... Center, analyzed the epidemiology and microbiology of co-infections ... well as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... cause of neuronal death in Parkinson,s disease is still ... be mistaken for foreign invaders and killed by the ... diseases like type I diabetes, celiac disease, and multiple ... April 16, 2014, in Nature Communications . , ... Parkinson,s disease; but if true, it could lead to ...
Breaking Medicine News(10 mins):Health News:Benaroya Research Institute evaluates immunology approach to blocking breast cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:Study sheds light on how the immune system protects children from malaria 2Health News:Is Parkinson's an autoimmune disease? 2
... submit abstracts to present their research at the ... to molecular imaging and nuclear medicineJune 13-17, 2009, ... molecular imaging is vital and state-of-the-art," said SNM ... society,s more than 17,000 molecular imaging and nuclear ...
... associated with an increased risk of fetal growth restriction ... bmj.com today. , Although some previous studies ... that any amount and type of caffeine intakefrom tea, ... as coffeeis linked with relatively slower fetal growth. ...
... Nov. 3 Pregis Corporation, a leading,international ... and specialty packaging solutions, will conduct an ... quarter results on Friday,November 14, 2008 at ... 800-591-6942;,International: 617-614-4909; Participant Passcode: 68623125. A replay ...
... QIAGEN N.V.,(Nasdaq: QGEN ) today announced the Webcast of ... at 9:30 a.m. EST on,Tuesday, November 11, and will include remarks ... Chief Financial Officer., What: Webcast ... 9:30 a.m. EST on November 11, Where: ...
... common correction techniques yield positive results, ROSEMONT, ... used to correct the condition known as clubfoot,have ... new study published,in the November 2008 issue of ... ). While both treatment strategies use different,approaches, each ...
... ANGELES, Nov. 3 World Champion athlete and ... debut as a member of the,California Governor,s Council ... speaking to the student body of NEW Academy ... and healthy lifestyles., (Photo: http://www.newscom.com/cgi-bin/prnh/20081103/AQM074 ), ...
Cached Medicine News:Health News:SNM to showcase the latest research in molecular imaging and nuclear medicine 2Health News:Consuming small amounts of caffeine when pregnant may affect the growth of an unborn child 2Health News:Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2008 Financial Results Call Set for November 11 2Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 2Health News:Non-Surgical Clubfoot Treatments Bring High Level of Success 3Health News:Laila Ali Debuts as Member of California Governor's Council on Physical Fitness and Sports 2
(Date:1/15/2014)... Jan. 15, 2014 Reportlinker.com announces that ... in its catalogue: ... and Market Analysis to 2022 ... Dermatitis - India Drug Forecast and Market ...
(Date:1/15/2014)... YORK , Jan. 15, 2014 ... report is available in its catalogue: ... for Advanced Drug Delivery Systems -- Focus ... STUDY OBJECTIVES ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 2Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 3Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 4Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 5Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 6Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 7Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 8Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 9Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 10Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 11Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 12Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 13Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 14Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 15Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 16Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 17Global Markets and Technologies for Advanced Drug Delivery Systems -- Focus on End Users 18Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4